METHOD FOR EVALUATING ANTI-INFECTIVE DRUGS, VACCINES, ETC. USING IMMORTALIZED MONOCYTIC… Application EP-3845639-A4 European Patent Office 11 May 2022
Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein Grant US-11318196-B2 United States of America 03 May 2022
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses Grant US-10500264-B2 United States of America 10 Dec 2019
Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein Grant US-9707287-B2 United States of America 18 Jul 2017
Attenuated dengue virus comprising mutations in the NS3 gene Grant US-RE45053-E1 United States of America 29 Jul 2014
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses Grant US-RE45016-E1 United States of America 15 Jul 2014
Attenuated dengue virus comprising mutations in the NS3 gene Grant US-7560118-B2 United States of America 14 Jul 2009
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses Grant US-7226602-B2 United States of America 05 Jun 2007